SK285192B6 - Použitie LHRH antagonistu na výrobu liečiva na liečenie neplodnosti - Google Patents

Použitie LHRH antagonistu na výrobu liečiva na liečenie neplodnosti Download PDF

Info

Publication number
SK285192B6
SK285192B6 SK1530-2000A SK15302000A SK285192B6 SK 285192 B6 SK285192 B6 SK 285192B6 SK 15302000 A SK15302000 A SK 15302000A SK 285192 B6 SK285192 B6 SK 285192B6
Authority
SK
Slovakia
Prior art keywords
lhrh
lhrh antagonist
treatment
stimulation
infertility
Prior art date
Application number
SK1530-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK15302000A3 (sk
Inventor
J�Rgen Engel
Hilde Riethm�Ller-Winzen
Thomas Reissmann
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of SK15302000A3 publication Critical patent/SK15302000A3/sk
Publication of SK285192B6 publication Critical patent/SK285192B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/52—Sperm; Prostate; Seminal fluid; Leydig cells of testes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Liquid Crystal Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1530-2000A 1998-04-23 1999-03-29 Použitie LHRH antagonistu na výrobu liečiva na liečenie neplodnosti SK285192B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8274398P 1998-04-23 1998-04-23
PCT/EP1999/002133 WO1999055357A1 (en) 1998-04-23 1999-03-29 Method for the treatment of fertility disorders

Publications (2)

Publication Number Publication Date
SK15302000A3 SK15302000A3 (sk) 2001-10-08
SK285192B6 true SK285192B6 (sk) 2006-08-03

Family

ID=22173160

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1530-2000A SK285192B6 (sk) 1998-04-23 1999-03-29 Použitie LHRH antagonistu na výrobu liečiva na liečenie neplodnosti

Country Status (24)

Country Link
US (1) US6319192B1 (pt)
EP (1) EP1082129B1 (pt)
JP (1) JP2002512975A (pt)
KR (1) KR100632722B1 (pt)
AT (1) ATE252910T1 (pt)
AU (1) AU752415B2 (pt)
BR (1) BR9909802A (pt)
CA (1) CA2330131C (pt)
CZ (1) CZ301912B6 (pt)
DE (1) DE69912422T2 (pt)
DK (1) DK1082129T3 (pt)
ES (1) ES2207941T3 (pt)
HU (1) HU228736B1 (pt)
IL (1) IL139027A0 (pt)
NO (1) NO326406B1 (pt)
NZ (1) NZ507405A (pt)
PL (1) PL195989B1 (pt)
PT (1) PT1082129E (pt)
RU (1) RU2221588C2 (pt)
SI (1) SI1082129T1 (pt)
SK (1) SK285192B6 (pt)
TR (1) TR200003063T2 (pt)
UA (1) UA66850C2 (pt)
WO (1) WO1999055357A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
US20060183973A1 (en) * 2001-01-12 2006-08-17 Kamrava Michael M Endoscopic devices and method of use
US8465412B2 (en) * 2001-01-12 2013-06-18 Michael Levy Uterine devices and method of use
US6623422B2 (en) * 2001-01-12 2003-09-23 Napoli, Llc Method and apparatus for assisted embryo implantation
WO2002067772A2 (en) * 2001-01-12 2002-09-06 Napoli, Llc. Intra-uterine devices and method of use
US6758806B2 (en) 2001-01-12 2004-07-06 Napoli, Llc Endoscopic devices and method of use
EP1908463B1 (en) * 2001-12-14 2011-09-28 Merck Serono SA Methods of inducing ovulation using a non-polypeptide camp level modulator
US7033314B2 (en) * 2002-01-11 2006-04-25 Fidelitycorp Limited Endoscopic devices and method of use
US20030186892A1 (en) * 2002-03-28 2003-10-02 Rajneesh Taneja Enhancement of endogenous gonadotropin production
US6695766B2 (en) 2002-04-26 2004-02-24 Olympia Womens Health Magnetic embryo transfer
EP1364658A1 (en) * 2002-05-24 2003-11-26 Applied Research Systems ARS Holding N.V. Use of varying ratios of gonadotrophins in controlled ovarian hyperstimulation
PL373991A1 (en) * 2002-06-07 2005-09-19 Ares Trading S.A. Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130137A (en) * 1989-08-09 1992-07-14 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders
DE4305225A1 (de) 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
DE19604231A1 (de) * 1996-01-29 1997-07-31 Schering Ag Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US5824548A (en) * 1996-05-29 1998-10-20 Wisconsin Alumni Research Foundation Method of increasing survival of cultured primate embryos in medium containing exogenous gonadotrophin releasor hormone
DE19712718C2 (de) * 1997-03-26 1999-09-23 Asta Medica Ag Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung
US5961444A (en) * 1997-10-17 1999-10-05 Medworks Corporation In vitro fertilization procedure using direct vision

Also Published As

Publication number Publication date
HUP0101528A3 (en) 2001-12-28
HU228736B1 (en) 2013-05-28
CA2330131C (en) 2011-10-25
CZ20003766A3 (cs) 2001-08-15
CA2330131A1 (en) 1999-11-04
SK15302000A3 (sk) 2001-10-08
PL195989B1 (pl) 2007-11-30
JP2002512975A (ja) 2002-05-08
RU2221588C2 (ru) 2004-01-20
TR200003063T2 (tr) 2001-02-21
PL343609A1 (en) 2001-08-27
NO20005145D0 (no) 2000-10-13
DK1082129T3 (da) 2004-01-26
NO20005145L (no) 2000-10-13
AU752415B2 (en) 2002-09-19
UA66850C2 (uk) 2004-06-15
KR100632722B1 (ko) 2006-10-16
DE69912422D1 (de) 2003-12-04
ATE252910T1 (de) 2003-11-15
NZ507405A (en) 2002-10-25
AU3702899A (en) 1999-11-16
SI1082129T1 (en) 2004-02-29
EP1082129A1 (en) 2001-03-14
WO1999055357A1 (en) 1999-11-04
US6319192B1 (en) 2001-11-20
HUP0101528A2 (hu) 2001-11-28
EP1082129B1 (en) 2003-10-29
ES2207941T3 (es) 2004-06-01
KR20010042873A (ko) 2001-05-25
BR9909802A (pt) 2000-12-26
NO326406B1 (no) 2008-11-24
PT1082129E (pt) 2004-03-31
IL139027A0 (en) 2001-11-25
CZ301912B6 (cs) 2010-07-28
DE69912422T2 (de) 2004-08-19

Similar Documents

Publication Publication Date Title
SK285192B6 (sk) Použitie LHRH antagonistu na výrobu liečiva na liečenie neplodnosti
Tayyar et al. Comparison between cycles of the same patients when using recombinant luteinizing hormone+ recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin+ rFSH and rFSH only
AU2794100A (en) Treatment of infertility
Hussien et al. The impact of different estrus synchronization programs on postpartum holstein dairy cow reproductive performance
Mohammadsadegh The impacts of eCG administration, 3 days before OVSYNCH on the treatment of inactive ovary of dairy cows
Pycock et al. The effect of the gonadotrophin-releasing hormone analog, buserelin, administered in diestrus on pregnancy rates and pregnancy failure in mares
Çoksüer et al. Acupuncture enhances chances of pregnancy in unexplained infertile patients who undergo a blastocyst transfer in a fresh-cycle
NZ536984A (en) Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
Ali et al. Ovarian hyper-stimulation protocols in good prognosis patients: agonist versus antagonist protocol, an Iraqi view
Patel et al. Effect of hormonal and herbal therapy at calving on postpartum estrus and fertility response and serum hormonal profile in crossbred cows
Maladkar et al. Letrozole: An emerging array of hope for infertile women
Masood et al. Factors affecting Embryo Quality and Pregnancy Outcome in Intra-Cytoplasmic Sperm Injection using Decapeptyl and Cetrorelix-A retrospective study
Pereira et al. Regulation of the hypothalamic-pituitary-gonadal axis and the manipulation of the estrous cycle of bovine females
MXPA00010284A (en) Method for the treatment of fertility disorders
Nayana et al. Characteristics of oestrus and conception rate in postpartum dairy cows induced ovulation by using 3000 iu of hCG in 5-day and 7-day cidr-based oestrus synchronisation protocols.
von Wolff et al. Increased Age—Case Discussion and IVF Treatments Suggested by Different Centres
Khurana et al. “One Size does not Fit All” during Ovarian Stimulation for IVF
Khalilzadeh et al. Uses of CIDR, FSH and GnRH for treatment of anoestrus syndrome in dairy cow
Kharche et al. Efficacy of two different oestrus synchronization protocols for enhancing reproductive efficiency of anoestrous ewes
Sharma et al. A NewShine on Intrauterine Insemination
Parmar et al. Estrus induction and fertility response in postpartum anoestrus surti buffaloes treated with norgestomet ear implants alone and in combination with PMSG
RU2150946C1 (ru) Способ лечения вторичного гипогонадизма и бесплодия у женщин
Valasi et al. Combined treatment of eCG and a non-selective inhibitor of phosphodiesterases for enhancing reproductive performance in ewes
Azem et al. First live birth following IVF–embryo transfer and use of GnRHa alone for ovarian stimulation
Davar et al. Clinical Effects of a microdose GnRH agonist flare regimen administered to poor responders undergoing ART cycles

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20190329